Skip to search formSkip to main contentSkip to account menu

neramexane

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
An observational study was conducted on the efficacy of Neramexane in a small cohort of Hispanic subjects who were diagnosed with… 
2009
2009
N-methyl-D-aspartate (NMDA) receptor antagonists have a potentially wide range of therapeutic applications. Unfortunately, potent… 
2007
2007
In this study we report the effects of neramexane, a novel amino-alkyl-cyclohexane derivative that is a non-competitive N-methyl… 
2006
2006
Effects of acamprosate and ionotropic uncompetitive N-methyl-D-aspartate receptor antagonists and group I metabotropic… 
Review
2006
Review
2006
Merz Pharmaceuticals GmbH and Forest Laboratories Inc are developing neramexane, an oral N-methyl-D-aspartate antagonist, as a… 
2004
2004
Antagonists acting at N-methyl-D-aspartate (NMDA) receptors have been demonstrated repeatedly to attenuate the expression of drug… 
Review
2002
Review
2002
Because of its widespread involvement in the physiology and pathology of the CNS, the glutamatergic system has gained…